Back to Results
First PageMeta Content
Clinical research / Drug discovery / Orphan drug / Pharmaceuticals policy / Rare disease / Orphan Drug Act / National Institute for Health and Clinical Excellence / Food and Drug Administration / Health / Pharmaceutical sciences / Clinical pharmacology


Rarity And Innovation 1 SLIDE 2
Add to Reading List

Document Date: 2009-04-08 12:51:50

Open Document

File Size: 957,38 KB

Share Result on Facebook

City

London / Millburn / /

Company

Alexion / /

Country

United Kingdom / United States / /

Facility

UK’s National Institute / Royal College of Physicians / National Institute / /

MedicalCondition

Gastrointestinal stromal tumor / Rare Diseases / Mucopolysaccharidosis / diseases / disease / Rare And Ultra‐Rare Disease / Rare disease / infections Rheumatoid arthritis ESRD Crohn’s disease Multiple sclerosis / Serious Prevalence Psoriasis Hepatitis C / /

Organization

National Institute for Health and Clinical Excellence / Royal College of Physicians / NHS / Citizens Council / UK’s National Institute for Health and Clinical Excellence / National Institute for Clinical Excellence / /

Person

Michael Rawlins / MARK ZITTER / /

Position

Chair / Chief Executive Officer / Chair of the UK / /

ProvinceOrState

New Jersey / /

Technology

Alpha / genetic engineering / drug development / /

URL

http /

SocialTag